• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症管理的临床决策支持系统与 NOGG 指南和骨科学专家的比较:一项验证性试点研究。

Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.

机构信息

Department of Medicine, Landspitali - University Hospital, Reykjavik, Iceland.

Rheumatology Division, Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, USA.

出版信息

BMC Med Inform Decis Mak. 2019 Feb 1;19(1):27. doi: 10.1186/s12911-019-0749-4.

DOI:10.1186/s12911-019-0749-4
PMID:30709348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6359836/
Abstract

BACKGROUND

Although osteoporosis is an easily diagnosed and treatable condition, many individuals remain untreated. Clinical decision support systems might increase appropriate treatment of osteoporosis. We designed the Osteoporosis Advisor (OPAD), a computerized tool to support physicians managing osteoporosis at the point-of-care. The present study compares the treatment recommendations provided by OPAD, an expert physician and the National Osteoporosis Guideline Group (NOGG).

METHODS

We performed a retrospective analysis of 259 patients attending the outpatient osteoporosis clinic at the University Hospital in Iceland. We entered each patient's data into the OPAD and recorded the OPAD diagnostic comments, 10-year risk of major osteoporotic fracture and treatment options. We compared OPAD recommendations to those given by the osteoporosis specialist, and to those of the NOGG.

RESULTS

Risk estimates made by OPAD were highly correlated with those from FRAX (r = 0.99, 95% CI 0.99, 1.00 without femoral neck BMD; r = 0.98, 95% CI, 0.97, 0.99 with femoral neck BMD. Reassurance was recommended by the expert, NOGG and the OPAD in 68, 63 and 52% of cases, respectively. Likewise, intervention was recommended by the expert, NOGG, and the OPAD in 32, 37 and 48% of cases, respectively. The OPAD demonstrated moderate agreement with the physician (kappa 0.51, 95% CI 0.41, 0.61) and even higher agreement with NOGG (kappa 0.69, 95% CI 0.60, 0.77).

CONCLUSION

Primary care physicians can use the OPAD to assess and treat patients' skeletal health. Recommendations given by OPAD are consistent with expert opinion and existing guidelines.

摘要

背景

尽管骨质疏松症是一种易于诊断和治疗的疾病,但仍有许多患者未得到治疗。临床决策支持系统可能会增加骨质疏松症的合理治疗。我们设计了 Osteoporosis Advisor(OPAD),这是一种用于在临床环境下支持医生管理骨质疏松症的计算机工具。本研究比较了 OPAD、一位专家医生和国家骨质疏松症指南小组(NOGG)提供的治疗建议。

方法

我们对在冰岛大学医院就诊的 259 名门诊骨质疏松症患者进行了回顾性分析。我们将每位患者的数据输入 OPAD,并记录 OPAD 的诊断意见、10 年内发生主要骨质疏松性骨折的风险和治疗选择。我们将 OPAD 的建议与骨质疏松症专家的建议和 NOGG 的建议进行了比较。

结果

OPAD 做出的风险估计与 FRAX 高度相关(无股骨颈 BMD 时 r=0.99,95%CI 0.99,1.00;有股骨颈 BMD 时 r=0.98,95%CI 0.97,0.99)。专家、NOGG 和 OPAD 分别建议 68%、63%和 52%的患者感到安心。同样,专家、NOGG 和 OPAD 分别建议 32%、37%和 48%的患者进行干预。OPAD 与医生之间的一致性中等(kappa 值为 0.51,95%CI 0.41,0.61),与 NOGG 的一致性更高(kappa 值为 0.69,95%CI 0.60,0.77)。

结论

初级保健医生可以使用 OPAD 来评估和治疗患者的骨骼健康。OPAD 给出的建议与专家意见和现有指南一致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/3954b8a70d49/12911_2019_749_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/90151a7179b4/12911_2019_749_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/4da73d754349/12911_2019_749_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/9cdc188a2dbf/12911_2019_749_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/3954b8a70d49/12911_2019_749_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/90151a7179b4/12911_2019_749_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/4da73d754349/12911_2019_749_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/9cdc188a2dbf/12911_2019_749_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b3a/6359836/3954b8a70d49/12911_2019_749_Fig4_HTML.jpg

相似文献

1
Clinical decision support system for the management of osteoporosis compared to NOGG guidelines and an osteology specialist: a validation pilot study.骨质疏松症管理的临床决策支持系统与 NOGG 指南和骨科学专家的比较:一项验证性试点研究。
BMC Med Inform Decis Mak. 2019 Feb 1;19(1):27. doi: 10.1186/s12911-019-0749-4.
2
A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis.一种用于骨质疏松症诊断、骨折风险评估及治疗的临床决策支持系统。
Comput Math Methods Med. 2015;2015:189769. doi: 10.1155/2015/189769. Epub 2015 Mar 1.
3
Impact of UK National Guidelines based on FRAX®--comparison with current clinical practice.基于 FRAX®的英国国家指南的影响——与当前临床实践的比较。
Clin Endocrinol (Oxf). 2010 Oct;73(4):452-6. doi: 10.1111/j.1365-2265.2010.03844.x.
4
Access to fracture risk assessment by FRAX and linked National Osteoporosis Guideline Group (NOGG) guidance in the UK-an analysis of anonymous website activity.在英国通过FRAX进行骨折风险评估及参考相关国家骨质疏松症指南小组(NOGG)指南的情况——对匿名网站活动的分析
Osteoporos Int. 2017 Jan;28(1):71-76. doi: 10.1007/s00198-016-3696-2. Epub 2016 Jul 20.
5
Osteoporosis Management in a Real Clinical Setting: Heterogeneity in Intervention Approach and Discrepancy in Treatment Rates when Compared with the NOGG and NOF Guidelines.真实临床环境中的骨质疏松症管理:与NOGG和NOF指南相比,干预方法的异质性及治疗率的差异
Exp Clin Endocrinol Diabetes. 2016 Sep;124(8):466-473. doi: 10.1055/s-0042-107671. Epub 2016 May 24.
6
Predicting fracture risk in osteoporosis: the use of fracture prediction tools in an osteoporosis clinic population.预测骨质疏松症的骨折风险:在骨质疏松症门诊人群中使用骨折预测工具
Postgrad Med J. 2016 May;92(1087):267-70. doi: 10.1136/postgradmedj-2015-133454. Epub 2016 Jan 20.
7
Impact of the NOGG and NOF Guidelines on the Indication of Bone Mineral Density in Routine Clinical Practice.NOGG和NOF指南对常规临床实践中骨密度指征的影响。
J Clin Densitom. 2015 Oct-Dec;18(4):533-8. doi: 10.1016/j.jocd.2015.08.001. Epub 2015 Sep 3.
8
A comparative study between the implementation of the FRIDEX calibration and the NOGG guideline in the management of osteoporosis in routine clinical practice.在常规临床实践中骨质疏松症管理方面,FRIDEX校准实施与NOGG指南实施的比较研究。
Reumatol Clin. 2017 Sep-Oct;13(5):258-263. doi: 10.1016/j.reuma.2016.05.007. Epub 2016 Jun 29.
9
[Usefulness of FRAX tool for the management of osteoporosis in the Spanish female population].[FRAX工具在西班牙女性人群骨质疏松症管理中的应用价值]
Med Clin (Barc). 2011 May 21;136(14):613-9. doi: 10.1016/j.medcli.2010.09.043. Epub 2011 Feb 24.
10
Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.预防糖皮质激素性骨质疏松症:在初级保健环境中评估实施 2017 年国家骨质疏松症指南专家组指南的临床审计。
J Clin Densitom. 2019 Jan-Mar;22(1):25-30. doi: 10.1016/j.jocd.2018.03.009. Epub 2018 Apr 12.

引用本文的文献

1
Decision aids in patients with osteoporosis: A scoping review.骨质疏松症患者的决策辅助工具:一项范围综述。
PLoS One. 2025 Jul 15;20(7):e0328230. doi: 10.1371/journal.pone.0328230. eCollection 2025.
2
Benefits of Clinical Decision Support Systems for the Management of Noncommunicable Chronic Diseases: Targeted Literature Review.临床决策支持系统在非传染性慢性病管理中的益处:针对性文献综述
Interact J Med Res. 2024 Nov 27;13:e58036. doi: 10.2196/58036.
3
The use of imputation in clinical decision support systems: a cardiovascular risk management pilot vignette study among clinicians.

本文引用的文献

1
A clinical decision support system for the diagnosis, fracture risks and treatment of osteoporosis.一种用于骨质疏松症诊断、骨折风险评估及治疗的临床决策支持系统。
Comput Math Methods Med. 2015;2015:189769. doi: 10.1155/2015/189769. Epub 2015 Mar 1.
2
Inadequate management for secondary fracture prevention in patients with distal radius fracture by trauma surgeons.创伤外科医生对桡骨远端骨折患者继发性骨折预防的管理不足。
Osteoporos Int. 2015 Jul;26(7):1959-63. doi: 10.1007/s00198-015-3103-4. Epub 2015 Mar 20.
3
Clinician's Guide to Prevention and Treatment of Osteoporosis.
临床决策支持系统中插补法的应用:一项针对临床医生的心血管风险管理试点案例研究
Eur Heart J Digit Health. 2024 Aug 10;5(5):572-581. doi: 10.1093/ehjdh/ztae058. eCollection 2024 Sep.
4
Opportunistic screening for osteoporosis using enhanced images based on dual-energy computed tomography material decomposition: a comparison with quantitative computed tomography.基于双能计算机断层扫描物质分解的增强图像对骨质疏松症进行机会性筛查:与定量计算机断层扫描的比较
Quant Imaging Med Surg. 2024 Jan 3;14(1):352-364. doi: 10.21037/qims-23-855. Epub 2023 Oct 27.
5
Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis.计算机化临床决策支持系统预防糖皮质激素诱导性骨质疏松症的效果。
Sci Rep. 2022 Sep 2;12(1):14967. doi: 10.1038/s41598-022-19079-7.
6
Digital health interventions for osteoporosis and post-fragility fracture care.用于骨质疏松症和脆性骨折后护理的数字健康干预措施。
Ther Adv Musculoskelet Dis. 2022 Mar 28;14:1759720X221083523. doi: 10.1177/1759720X221083523. eCollection 2022.
骨质疏松症防治临床指南
Osteoporos Int. 2014 Oct;25(10):2359-81. doi: 10.1007/s00198-014-2794-2. Epub 2014 Aug 15.
4
Failure in the application of fragility fracture prevention guidelines.脆性骨折预防指南应用失败。
Ann R Coll Surg Engl. 2014 Jul;96(5):381-5. doi: 10.1308/003588414X13946184901164.
5
Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013.英国绝经后妇女和老年男性骨质疏松症的诊断和管理:国家骨质疏松症指南小组(NOGG) 2013 年更新。
Maturitas. 2013 Aug;75(4):392-6. doi: 10.1016/j.maturitas.2013.05.013. Epub 2013 Jun 27.
6
Management of osteoporosis in primary care before and after the result of densitometry: treatments in real practice versus the recommended by guidelines. CANAL study.骨密度测量结果前后初级保健中骨质疏松症的管理:实际治疗与指南推荐治疗。CANAL研究。
Reumatol Clin. 2013 Sep-Oct;9(5):269-73. doi: 10.1016/j.reuma.2013.01.011. Epub 2013 Jun 2.
7
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.欧洲绝经后妇女骨质疏松症的诊断和管理指南。
Osteoporos Int. 2013 Jan;24(1):23-57. doi: 10.1007/s00198-012-2074-y. Epub 2012 Oct 19.
8
Osteoporosis: burden, health care provision and opportunities in the EU: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).骨质疏松症:欧盟的负担、医疗保健提供及机遇:与国际骨质疏松症基金会(IOF)和欧洲制药工业协会联合会(EFPIA)合作编写的报告
Arch Osteoporos. 2011;6:59-155. doi: 10.1007/s11657-011-0060-1.
9
Fracture risk assessment.骨折风险评估。
Clin Biochem. 2012 Aug;45(12):887-93. doi: 10.1016/j.clinbiochem.2012.05.001. Epub 2012 May 8.
10
Assessment of fracture risk.骨折风险评估。
Curr Osteoporos Rep. 2012 Mar;10(1):28-41. doi: 10.1007/s11914-011-0093-9.